{"pmid":32348050,"title":"[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].","text":["[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak].","The current epidemic of SARS-CoV-2 infection poses new challenges in the management of patients with gastrointestinal or liver disease. Consultations with patients with chronic diseases should ideally be done via telemedicine and treatments administered at home if possible. The latter should be maintained in non-infected subjects to limit the risk of decompensation of their underlying disease. In the event of proven infection, immunomodulatory or biological treatments will tend to be reduced or discontinued unless the disease is in a severely active phase. Elective endoscopy should be postponed, and urgent procedures should be performed with appropriate personal protective equipment.","Rev Med Suisse","Restellini, Sophie","Buyse, Sophie","Godat, Sebastien","Goossens, Nicolas","Maillard, Michel H","32348050"],"abstract":["The current epidemic of SARS-CoV-2 infection poses new challenges in the management of patients with gastrointestinal or liver disease. Consultations with patients with chronic diseases should ideally be done via telemedicine and treatments administered at home if possible. The latter should be maintained in non-infected subjects to limit the risk of decompensation of their underlying disease. In the event of proven infection, immunomodulatory or biological treatments will tend to be reduced or discontinued unless the disease is in a severely active phase. Elective endoscopy should be postponed, and urgent procedures should be performed with appropriate personal protective equipment."],"journal":"Rev Med Suisse","authors":["Restellini, Sophie","Buyse, Sophie","Godat, Sebastien","Goossens, Nicolas","Maillard, Michel H"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348050","source":"PubMed","week":"202018|Apr 27 - May 03","topics":["Prevention"],"weight":1,"_version_":1665441658296074240,"score":8.599203,"similar":[{"pmid":32279064,"title":"Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.","text":["Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease-2019 (COVID -19) disease. Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed.","Indian Pediatr","Matthai, John","Shanmugam, Naresh","Sobhan, Prasanth","32279064"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease-2019 (COVID -19) disease. Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed."],"journal":"Indian Pediatr","authors":["Matthai, John","Shanmugam, Naresh","Sobhan, Prasanth"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279064","week":"202016|Apr 13 - Apr 19","source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"e_drugs":["Serine"],"_version_":1664636873215049728,"score":207.50648},{"pmid":32253172,"title":"Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?","text":["Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?","Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), has posed a serious threat to global health and is currently causing a major pandemic. While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract. This involvement may have important implications to the disease management, transmission, and prognosis, especially in patients with pre-existing hepatic or digestive co-morbidities. In this review, the characteristics and possible explanations of hepatic and gastrointestinal involvement caused by SARS-CoV-2 infection are summarized, adding to our knowledge of the spectrum of COVID-19. In addition, preventive measures implemented in endoscopy departments to prevent further dissemination of SARS-CoV-2 infection are proposed.","Arab J Gastroenterol","Musa, Sherief","32253172"],"abstract":["Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), has posed a serious threat to global health and is currently causing a major pandemic. While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract. This involvement may have important implications to the disease management, transmission, and prognosis, especially in patients with pre-existing hepatic or digestive co-morbidities. In this review, the characteristics and possible explanations of hepatic and gastrointestinal involvement caused by SARS-CoV-2 infection are summarized, adding to our knowledge of the spectrum of COVID-19. In addition, preventive measures implemented in endoscopy departments to prevent further dissemination of SARS-CoV-2 infection are proposed."],"journal":"Arab J Gastroenterol","authors":["Musa, Sherief"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253172","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ajg.2020.03.002","keywords":["covid-19","endoscopy","gastrointestinal tract","liver","sars-cov-2"],"source":"PubMed","topics":["Prevention","Diagnosis","Mechanism"],"weight":1,"_version_":1664640769722417152,"score":202.71135},{"pmid":32327904,"pmcid":"PMC7167410","title":"SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant.","text":["SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant.","The current pandemic due to the severe acute respiratory syndrome coronavirus 2 has caused an extreme burden for health care systems globally, and the number of cases is expected to continue to increase, at least in the immediate future. The virus is estimated to have infected more than 1.5 million individuals. The available reports suggest that gastrointestinal (GI) involvement in coronavirus disease 2019 (COVID-19) is common and in some cases the GI symptoms may precede the respiratory symptoms. In addition to direct effects of severe acute respiratory syndrome coronavirus 2, the infected patients remain at risk for the complications commonly managed by gastroenterology and hepatology consultants. The most commonly reported GI manifestation of COVID-19 is diarrhea, which is reported in a third to up to more than half of the patients. Mild to moderate elevation of the liver enzymes are also common, although no case of acute liver failure has been reported so far. Many of the medications used for treatment of COVID-19 can also be associated with GI symptoms or liver injury and can be included in the differential diagnosis in these patients. Although the diagnosis of the infection is currently based on RNA analysis in respiratory samples, the available literature on fecal shedding of this virus suggests that fecal RNA testing might prove to be a useful diagnostic test. It is reasonable to delay all non-urgent endoscopic procedures during the peak of the pandemic and use additional protective equipment such as N95 respirators during endoscopy while most patients can be considered high risk for having been exposed to the virus.","World J Gastroenterol","Hajifathalian, Kaveh","Mahadev, Srihari","Schwartz, Robert E","Shah, Shawn","Sampath, Kartik","Schnoll-Sussman, Felice","Brown, Robert S Jr","Carr-Locke, David","Cohen, David E","Sharaiha, Reem Z","32327904"],"abstract":["The current pandemic due to the severe acute respiratory syndrome coronavirus 2 has caused an extreme burden for health care systems globally, and the number of cases is expected to continue to increase, at least in the immediate future. The virus is estimated to have infected more than 1.5 million individuals. The available reports suggest that gastrointestinal (GI) involvement in coronavirus disease 2019 (COVID-19) is common and in some cases the GI symptoms may precede the respiratory symptoms. In addition to direct effects of severe acute respiratory syndrome coronavirus 2, the infected patients remain at risk for the complications commonly managed by gastroenterology and hepatology consultants. The most commonly reported GI manifestation of COVID-19 is diarrhea, which is reported in a third to up to more than half of the patients. Mild to moderate elevation of the liver enzymes are also common, although no case of acute liver failure has been reported so far. Many of the medications used for treatment of COVID-19 can also be associated with GI symptoms or liver injury and can be included in the differential diagnosis in these patients. Although the diagnosis of the infection is currently based on RNA analysis in respiratory samples, the available literature on fecal shedding of this virus suggests that fecal RNA testing might prove to be a useful diagnostic test. It is reasonable to delay all non-urgent endoscopic procedures during the peak of the pandemic and use additional protective equipment such as N95 respirators during endoscopy while most patients can be considered high risk for having been exposed to the virus."],"journal":"World J Gastroenterol","authors":["Hajifathalian, Kaveh","Mahadev, Srihari","Schwartz, Robert E","Shah, Shawn","Sampath, Kartik","Schnoll-Sussman, Felice","Brown, Robert S Jr","Carr-Locke, David","Cohen, David E","Sharaiha, Reem Z"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32327904","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3748/wjg.v26.i14.1546","keywords":["covid-19","gastroenterology","hepatology","liver","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1665420537476677633,"score":176.38066},{"pmid":32335946,"title":"Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","text":["Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19.","Dig Endosc","Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro","32335946"],"abstract":["All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19."],"journal":"Dig Endosc","authors":["Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335946","week":"202018|Apr 27 - May 03","doi":"10.1111/den.13703","keywords":["covid-19","corona virus","gastrointestinal endoscopy","personal protective equipment"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Japan","anesthesia","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"_version_":1665172301964902401,"score":175.18372},{"pmid":32281689,"title":"COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","text":["COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures.","Dig Endosc","Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant","32281689"],"abstract":["A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures."],"journal":"Dig Endosc","authors":["Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281689","week":"202016|Apr 13 - Apr 19","doi":"10.1111/den.13693","keywords":["covid-19","coronavirus","sars-cov-2","endoscopy","pandemic"],"source":"PubMed","topics":["Transmission","Prevention"],"weight":1,"locations":["Wuhan","China","China","United States","US","US"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"_version_":1664636703936086016,"score":173.86104}]}